CFN Enterprises Inc.
CFN Enterprises Inc. is a U.S.-based business services company that combines a cannabis-industry sponsored content and marketing operation with a newer Ranco business focused on white label manufacturing, co-packing, logistics, and product distribution. The CFN Business sells promotional packages to public and private companies in the cannabis sector, while Ranco performs outsourced production and fulfillment work for customers that need packaging, manufacturing, and shipping support. Management also says it is building an e-commerce network for general wellness CBD products, which adds a consumer-facing distribution layer to the business mix. The company’s recent filings show that Ranco has become the main revenue driver, while the legacy media/marketing business remains part of the platform. CFN Enterprises is also operating under significant liquidity pressure and has disclosed substantial doubt about its ability to continue as a going concern.
Fiscal year 2025 · change from previous year
Development 2020–2025
Business
Share of revenuePromotional content packages, advertising placements, and investor-focused media sold to cannabis-related companies.
Outsourced production services where customer products are processed, packaged, and prepared for shipment.
Sale of imported packaging, hardware, and bulk raw materials that are transferred to customers after shipment.
Fulfillment, shipping, and logistics support provided to customers as part of the Ranco business.
Online sales of general wellness CBD products through the company’s e-commerce network.
Customers
CFN’s customer base is split between cannabis-industry issuers seeking investor awareness and commercial customers using Ranco for outsourced production and fulfillment. The media business sells to public companies that want to expand their shareholder base and private companies that are trying to build visibility ahead of a potential capital raise or public listing. Ranco serves customers that already have products and need manufacturing, co-packing, packaging procurement, shipping, and logistics support without building those capabilities in-house. The company also appears to sell product through an e-commerce channel aimed at consumers of general wellness CBD products, though this is still a smaller and developing part of the business. Customer demand is therefore tied both to cannabis capital-markets activity and to the operational needs of small brands that outsource production and fulfillment.
Public and private cannabis companies buy sponsored content, press releases, videos, podcasts, and email campaigns to build awareness and attract investors.
Companies with finished goods or product concepts use Ranco for white label manufacturing, co-packing, and related labor-intensive processing.
Customers buy imported packaging, hardware, raw materials, shipping, and logistics services to outsource supply-chain execution.
Consumers purchase general wellness CBD products through the company’s online network, supporting a smaller direct-to-consumer revenue stream.
Strategy
Management’s near-term strategy is to scale the Ranco business, which has become the main revenue engine, while continuing to operate the legacy CFN media platform. The company is also trying to broaden its model by launching an e-commerce network for general wellness CBD products, which could diversify revenue away from sponsored content and outsourced manufacturing. In the filings, management emphasizes acquiring inventory, retaining new customers, and increasing operating scale, suggesting a focus on volume growth rather than margin optimization. At the same time, the company says it will pursue strategic transactions and opportunities, which indicates that capital raising or corporate restructuring may remain part of the plan. These priorities matter because the business currently depends on working-capital-intensive operations and external financing to support growth.
Ranco is now the primary source of revenue, so expanding customer volume and service breadth is central to the company’s survival and growth.
A consumer-facing CBD channel could diversify revenue and reduce dependence on sponsored content and B2B service contracts.
The company has a working capital deficit and substantial debt, so capital access is necessary to fund operations and inventory.
Geography
The filings do not provide a country-by-country revenue split, so the business profile is best understood as U.S.-based with operational exposure to overseas sourcing. CFN is headquartered in the United States and sells primarily into U.S.-linked cannabis and consumer markets. A meaningful part of the Ranco model depends on products manufactured overseas, including packaging, hardware, and bulk raw materials, which are then shipped to customers. That creates exposure to international supply chains, freight costs, and cross-border lead times even if end customers are largely domestic. The company’s e-commerce CBD initiative also suggests a broader U.S. consumer reach, but no authoritative geographic revenue disclosure was provided.
Risks
The most immediate risk is liquidity, because the company has disclosed substantial doubt about its ability to continue as a going concern and relies on debt or equity financing to fund operations. Ranco’s growth model is working-capital intensive: it requires inventory purchases, overseas sourcing, shipping, and labor before revenue is recognized, which can strain cash when demand rises. The business is also exposed to concentration and regulatory risk in the cannabis and CBD markets, where customer demand, advertising rules, and product compliance can change quickly. Because a large part of the product flow depends on overseas suppliers and freight, the company is vulnerable to supply-chain disruptions, shipping delays, and cost inflation. Finally, the company’s use of related-party sourcing for mitragynine-related raw materials and its small scale increase execution and governance risk.
The company disclosed substantial doubt about its ability to continue as a going concern and says it needs debt or equity capital to fund operations.
Exposure: All operations
Ranco requires inventory, labor, shipping, and overseas procurement before cash is collected, which can pressure liquidity as revenue grows.
Exposure: Ranco business
The company serves cannabis-industry customers and is launching CBD products, both of which are subject to changing legal and advertising rules.
Exposure: CFN Business and CBD e-commerce
Packaging, hardware, and raw materials are sourced overseas, making the business sensitive to shipping delays and logistics costs.
Exposure: Ranco sourcing and fulfillment
The company sourced mitragynine-related bulk raw materials from a related party before terminating the arrangement, which raises dependency and governance concerns.
Exposure: Raw material sourcing
Accounting
Judgemental itemsThe company recognizes sponsored content over the contract period and Ranco revenue when services are complete or goods are shipped, which can create timing differences across quarters.
Impact: Quarterly revenue comparability
Management recorded inventory reserve expense and values inventory at the lower of cost or net realizable value, which can materially affect product margins.
Impact: Gross margin and asset carrying value
Notes payable and interest expense are significant relative to the company’s size and can drive losses and financing-related volatility.
Impact: Net income and liquidity presentation
Substantial doubt about continuation affects how investors interpret asset values, liabilities, and future financing assumptions.
Impact: Financial statement risk assessment
Similar listed companies
Publicly listed companies with a comparable business focus.
CV Sciences, Inc.
CVSI · Pharmaceutical Preparations
CF Industries Holdings, Inc.
CF · Agricultural Chemicals
CNBX Pharmaceuticals Inc.
CNBX · Pharmaceutical Preparations
cbdMD, Inc.
YCBD · Perfumes, Cosmetics & Other Toilet Preparations
Target Group Inc.
CBDY · Medicinal Chemicals & Botanical Products
Cigna Group
CI · Hospital & Medical Service Plans
Cigna Group is a U.S.-based global health company that combines health benefits and pharmacy/medical services through two core segments: Cigna Healthcare and Evernorth Health Services.
Last updated: 11/08/2026